Abstract
Background: Multiple myeloma is a multifocal hematological disorder, which shows a proliferation of malignant plasma cells in the bone marrow, it represents approximately 1% of all malignancy, causing about 20% of deaths from hematological malignancies. Cyclin D1 is considered an important factor in the cell cycle control; dysregulation of cyclin D1 has an oncogenic role in multiple myeloma patients and can affect their prognosis
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
